Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia

doi:10.5500/wjt.v7.i5.269

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6292)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

339

WORD

291

HTML

3006

Figures (1-1)

186

Tables (1-3)

211

Sum=4033

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1077

Download

1182

Sum=2259

Oct 24, 2017 (publication date) through Aug 27, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Transplant. Oct 24, 2017; 7(5): 269-275
Published online Oct 24, 2017. doi: 10.5500/wjt.v7.i5.269

Table 1 Demographics and outcomes n (%)

Variable	All sample (n = 319)	PyVAN negative (n = 272)	PyVAN positive (n = 47)
Age (mean, yr)	53	51	53.1
Male	210 (65.8)	177 (65.1)	33 (70.2)
Black	86 (27.0)	67 (24.6)	19 (40.4)
Diabetes mellitus	86 (27.0)	71 (26.1)	15 (32.0)
CMV D+/R-	58 (18.2)	49 (18.0)	9 (19.1)
DDKT	174 (54.5)	140 (51.5)	34 (72.3)
Induction immunosuppression
Thymoglobulin	118 (37.0)	97 (35.7)	21 (44.7)
Basiliximab	143 (44.8)	124 (45.6)	19 (40.4)
Daclizumab	56 (17.6)	50 (18.4)	6 (12.8)
Delayed graft function	58 (18.2)	47 (17.3)	11 (23.4)
Acute rejection	59 (18.5)	44 (16.2)	15 (32.0)
Graft loss	17 (5.3)	13 (4.8)	4 (8.5)
Death	21 (6.6)	15 (5.5)	6 (12.8)

DDKT: Deceased-donor kidney transplantation; PyVAN: Polyoma-virus associated nephropathy.

Citation: Azar MM, Assi R, Valika AK, Banach DB, Hall IE, Landry ML, Malinis MF. Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia. World J Transplant 2017; 7(5): 269-275
URL: https://www.wjgnet.com/2220-3230/full/v7/i5/269.htm
DOI: https://dx.doi.org/10.5500/wjt.v7.i5.269